Skip to main content

Peer Review reports

From: 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)

Original Submission
27 Dec 2023 Submitted Original manuscript
1 Jan 2024 Author responded Author comments - Tomas Kazda
22 May 2024 Author responded Author comments - Tomas Kazda
Resubmission - Version 2
1 Jan 2024 Submitted Manuscript version 2
Publishing
3 Jun 2024 Editorially accepted
15 Jun 2024 Article published 10.1186/s12885-024-12469-2

You can find further information about peer review here.

Back to article page